xmlui.themes.about.link
Instituto de Investigación Marqués de Valdecilla (IDIVAL): Envíos recientes
Mostrando ítems 181-200 de 961
-
Migraine treatment: quo vadis? Real-world data study (2015-2022) in Spain
(BioMed Central, 2024) -
Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review
(Frontiers Media S.A., 2024) -
Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids
(Nature Publishing Group, 2024) -
Simplified risk stratification based on cardiopulmonary exercise test: A Spanish two-center experience
(John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute, 2024) -
Teriflunomide-induced Raynaud's phenomenon: a serious adverse event, previously unreported
(Springer Verlag, 2022) -
Hepatitis inmunomediada: conceptos básicos y tratamiento
(Asociación Mexicana de Gastroenterología, 2024)